HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)-Reference-Cited by-同舟云学术

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Published:2016-12 Issue:3 Volume:121 Page:364-373
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Linge Annett,Lohaus Fabian,Löck Steffen,Nowak Alexander,Gudziol Volker,Valentini Chiara,von Neubeck Cläre,Jütz Martin,Tinhofer Inge,Budach Volker,Sak Ali,Stuschke Martin,Balermpas Panagiotis,Rödel Claus,Grosu Anca-Ligia,Abdollahi Amir,Debus Jürgen,Ganswindt Ute,Belka Claus,Pigorsch Steffi,Combs Stephanie E.,Mönnich David,Zips Daniel,Buchholz Frank,Aust Daniela E.,Baretton Gustavo B.,Thames Howard D.,Dubrovska Anna,Alsner Jan,Overgaard Jens,Krause Mechthild,Baumann Michael

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference56 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study;Adelstein;J Clin Oncol,1993

3. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

4. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy;Huguenin;J Clin Oncol,2004

5. Radiation oncology in the era of precision medicine;Baumann;Nat Rev Cancer,2016

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer;Radiotherapy and Oncology;2024-10

2. Potential Role of Lymphocyte CD44 in Determining Treatment Selection Between Stereotactic Body Radiation Therapy and Surgery for Early-Stage Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-09

3. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial;The Lancet Oncology;2024-05

4. Integrated analysis of disulfidptosis-related genes SLC7A11, SLC3A2, RPN1 and NCKAP1 across cancers Running title: Disulfidptosis-related genes across cancers;2024-04-05

5. Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma – A DAHANCA 19 study;Radiotherapy and Oncology;2024-04